Refine by
Pharmaceutical Health Articles & Analysis
51 news found
They are suitable for small to medium-sized bottles used for wine, vodka, pharmaceuticals, cosmetics, juices, and other beverages. Unlike ordinary screw or crown caps, ROPP caps ensure product integrity and allow resealing, making them the ideal choice for premium and regulated beverage products. ...
Alfa Chemistry’s precise production techniques ensure that their HGH human growth hormone for sale meets the rigorous standards required for pharmaceutical applications. Oat β-Glucan: Health and Nutrition Lastly, Oat β-Glucan (CAS 9051-97-2, also known as Avena Sativa L) showcases Alfa Chemistry’s dedication to health and ...
Mentabinol® - Formulation utilizing pharmaceutical-grade botanical extract, L-theanine, and THC molecules extracted from cannabis. ...
Canaquest Medical Corp (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced that it has been awarded the Best Global Medical Cannabinoid Development Company 2023, in its eighth annual Healthcare and ...
CD Formulation, a leading CRO service provider in the pharmaceutical formulation industry, has recently announced its latest expansion into the realm of glass and plastic packaging materials. ...
Portal Instruments is pleased to announce the appointment of Dr. Veena Rao, PhD, as Chief Business Officer, effective December 5th, 2022. Dr. Rao will lead the identification, evaluation, and negotiation of partnership opportunities for Portal. In addition, Dr. Rao, in close collaboration with the CEO and cross-functional team, will guide the company’s short and long-term commercial ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. ...
Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announces the Company was awarded the ?Promising Health Biotech Company of the Year' Gold Leaf Award at the BIONATION Conference, currently held in Ottawa, Canada. An initiative of BIOTECanada, the national industry association, coveted Gold ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced receipt of approximately $16 million of international procurement orders for oral TPOXX® (tecovirimat) in August and early September, including an approximate $10 million order by the European Commission, through funds from the European ...
(“Fosun Pharma”, stock code : 600196.SH; 02196.HK) announced that Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. (“Fosun Pharmaceutical Industry”), a controlled subsidiary, signed an exclusive sales agency and development agreement with Switzerland ’s Neovii Pharmaceuticals AG (hereinafter referred to ...
25 European companies from the Biotech, Medtech, Innovative Services & Digital Health sectors, committed to patients, selected by the European clusters, will present their innovation to a jury composed of HTFC’s sponsors and the HTID health innovation ecosystem. ...
xCures, Inc. is proud to partner with Vault Health, a decentralized research and workforce screening company, to facilitate the enrollment of pancreatic cancer patients in Faeth Therapeutics’ NEAAR-001 research study. NEAAR-001 is a clinical trial of a precision nutrition-based diet that restricts specific amino acids that preclinical studies suggest are necessary for cancer growth. The ...
ByxCures
More than 750 private investors participated in the pharmaceutical company, which has already launched 2 out of 3 reimbursable pharmaceuticals for international distribution on the market. The pharmaceutical company has been developing and marketing generics for prescription medicines in the field of skin diseases. ...
To learn more about this EB study, view the detailed study description on the National Institutes of Health (NIH) clinicaltrials.gov website. Learn more about InMed’s INM-755 EB study: https://www.inmedpharma.com/pharmaceutical/inm-755-for-epidermolysis-bullosa/ What is epidermolysis bullosa? ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced a collaboration with KaliVir Immunotherapeutics to make TPOXX® (tecovirimat) available for use with KaliVir’s proprietary oncolytic vaccinia immunotherapy platform. ...
Canadian biotechnology company ANGANY (www.ANGANY.com) is presenting its immunotherapy platform at BIO International Convention, a critical rendez-vous for the global pharmaceutical industry which takes place in San Diego, California between June 13th and 16th. ...
Surgical has signed the Department of Health and Human Services (HHS) climate pledge initiative NewGen in partnership with the White House to mobilize the healthcare sector to reduce carbon emissions. ...
Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoid Bolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBT THCV has been researched for a variety of potential benefits VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a ...